TOOLE JOHN J

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
11
Insider Sells Sum
$18.76M

Insider Activity of TOOLE JOHN J

The largest sale of all time was on 2006-08-16 and amounted to 51432 shares of Gilead Sciences, Inc. for $3.28M.

Biography of TOOLE JOHN J

No biography is available at this moment.

2007-04-25SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
19,148
0.0041%
$83.08$1.59M+2.11%
2007-02-23SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
20,000
0.0043%
$73.27$1.47M+11.56%
2006-11-17SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
36,328
0.0078%
$68.57$2.49M+10.04%
2006-08-16SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
51,432
0.0112%
$63.69$3.28M+10.27%
2006-02-09SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
35,472
0.0078%
$59.34$2.11M+8.26%
2005-11-22SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
20,000
0.0044%
$53.97$1.08M+13.12%
2005-10-25SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
50,000
0.0108%
$47.35$2.37M+25.19%
2005-05-02SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
57,900
0.0127%
$37.41$2.17M+27.33%
2004-11-10SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
33,260
0.0076%
$35.99$1.2M+7.7%
2004-11-02SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
9,400
0.0022%
$35.33$332,102+10.09%
2004-08-30SaleGilead Sciences, Inc.
GILD
SVP, Clinical Research
10,000
0.0047%
$68.63$686,306+7.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.